Promore Pharma
STOCKHOLM, SE / ACCESSWIRE / November 19, 2021 / Promore Pharma (STO:PROMO) (FRA:8T0)
Promore Pharma AB (publ) publishes its interim report for the third quarter 2021 on 23 November 2021.
The next day, 24 November, the company will host a webcast telephone conference at 09.00 CET, with President and CEO Jonas Ekblom and CFO Erik Magnusson, where an update for the quarter and upcoming activities. After the presentation there will be a Q&A session. The conference call will be held in English and can be accessed via computer, tablet, or telephone.
The number of attendees is limited, please register for the conference in advance on the following link:
https://attendee.gotowebinar.com/register/3513796589233231628
The conference call will be recorded and made available on the company´s website after the call, and on
Västra Hamnen Corporate Finance Youtube channel.
For additional information, please contact
Jonas Ekblom, CEO
Phone: [+46] 736 777 540
E-mail: jonas.ekblom@promorepharma.com
Erik Magnusson, CFO
Phone: [+46] 708 565 245
E-mail: erik.magnusson@promorepharma.com
Promore Pharmas Certified Adviser is Erik Penser Bank
Tel: [+46] 8-463 83 00
E-mail: certifiedadviser@penser.se
Promore Pharma in brief
Promore Pharma is a biopharmaceutical company specialized in the development of therapeutic peptides. The company's aim is to develop first-in-category pharmaceuticals for indications with high unmet medical needs, where very few efficacious prescription pharmaceuticals are available. Promore Pharma's two projects are undergoing clinical development and have a very strong safety profile since the products are based on endogeneous substances that are administered locally. The leading project, ensereptide (PXL01), that will be used for prevention of post-surgical scarring, is being prepared for a clinical phase II-trial if the peptide can prevent the formation of unesthetical scars on the skin. Ropocamptide (LL-37) has recently been evaluated in a clinical phase IIb study with positive results in patients with venous leg ulcers (VLUs). The product candidates can also be deployed for other indications, such as preventing unfavorable tissue attachments (adhesions) after different kinds of surgical procedures and treatment of diabetic foot ulcers. The company is listed on Nasdaq First North Growth Market.
Attachments
Invitation to Conference Call regarding Promore Pharma's Interim Report for the Third Quarter 2021
SOURCE: Promore Pharma
View source version on accesswire.com:
https://www.accesswire.com/673758/Invitation-to-Conference-Call-Regarding-Promore-Pharmas-Interim-Report-for-the-Third-Quarter-2021
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Sauce Labs Introduces Sauce AI for Insights: Purpose-Built AI Agents That Transform Software Quality Data Into Instant Engineering Intelligence3.11.2025 16:00:00 CET | Press release
Purpose-Built AI Agents Eliminate Hours of Manual Test Analysis, Accelerating Release Cycles and Empowering Engineering Teams to Ship High-Quality Applications with Unprecedented Speed and Confidence SAN FRANCISCO, CA / ACCESS Newswire / November 3, 2025 / Sauce Labs, the leading platform for continuous quality, today announced Sauce AI for Insights, a groundbreaking suite of AI-powered data and analytics capabilities that fundamentally transforms how engineering teams analyze, understand, and act on real-time test execution and runtime data to deliver quality releases at speed - while offering enterprise-grade rigorous security and compliance controls. As the industry's first AI agent purpose-built for software quality intelligence, Sauce AI for Insights converts one of the most critical bottlenecks in modern software development into a strategic advantage: the overwhelming volume of test data that slows decision-making and delays releases now accelerates developer productivity and en
Affiliate of Pacific Avenue Capital Partners Completes Acquisition of FLSmidth Cement from FLSmidth & Co. A/S3.11.2025 16:00:00 CET | Press release
LOS ANGELES, CA / ACCESS Newswire / November 3, 2025 / Pacific Avenue Capital Partners ("Pacific Avenue"), a leading global private equity firm focused on corporate carve-outs and other complex situations in the middle market, today announced it has completed the acquisition of FLSmidth Cement A/S ("FLSmidth Cement" or "Company"), from FLSmidth & Co. A/S (CPH:FLS) ("FLSmidth"). With the completion of the transaction, FLSmidth Cement will operate under the new name Fuller Technologies ("Fuller"), marking the beginning of its next chapter as an independent, technology-driven leader serving the global cement sector. Fuller is a leading solutions provider for the cement production industry focused on providing aftermarket parts and services to as well as new and replacement equipment for cement plants around the globe. The Company has manufacturing locations in North America, Europe, and Asia, and its global installed base spans over 1,400 of the world's approximate 2,700 cement plants. Wi
Scam Encounters Every Four Days: Mexico's Financial Toll3.11.2025 13:00:00 CET | Press release
This study of 1,000 Mexican adults reveals that over three-quarters have encountered a scam, with an average of one scam encounter happening every four days, equating to 86 scam encounters on average per person per year in Mexico. THE HAGUE, NL / ACCESS Newswire / November 3, 2025 / Additionally, nearly 3/5 of Mexican adults claim to have experienced a scam in the last year, with each scam victim being scammed on average 1.8 times. With widespread financial losses Shopping scams (55%), investment scams (48%) and unexpected money scams (47%) are the most common types of scams in Mexico, with some having money stolen via email while others received kidnapping threats. Additionally, over 1/3 of Mexican adults claim to have lost money to scams in the last year. Wire or bank transfers (55%) and debitcard payments (21%) are the most common methods used by scammers to receive payment. Of those who have experienced being scammed, 2/3 have reported the scam to the payment service, and half of t
Market Logic Software and Euromonitor International Announce New Data Integration: DeepSights(TM) to Enhance AI-Driven Insights for Customers3.11.2025 10:00:00 CET | Press release
BERLIN, DE / ACCESS Newswire / November 3, 2025 / Market Logic Software, a leading provider of insights management solutions, is proud to announce a strategic integration with Euromonitor International, a global data analytics company. This collaboration will enable shared customers to seamlessly access Euromonitor's unparalleled market intelligence through Market Logic's AI for insights, platform, DeepSightsTM. The integration will provide a comprehensive streamlined experience for enterprises seeking growth. Market Logic has more than a decade's experience delivering solutions that allow businesses to centralize and leverage their consumer and market insights effectively. By integrating Euromonitor's extensive market research and intelligence content directly into DeepSights, shared clients will now benefit from a more unified and efficient insights management experience, powered by AI. "We are excited to be deepening our ongoing partnership with Euromonitor," said Olaf Lenzmann, Chi
EESystem Triumphs Again: Courts Deem Jason Shurka's Claims “Baseless” and “Futile”31.10.2025 14:25:00 CET | Press release
Judges Continue to Side with Energy Enhancement System as Jason Shurka's Legal Maneuvers Collapse LAS VEGAS, NV / ACCESS Newswire / October 31, 2025 /Energy Enhancement System, LLC ("EES") has achieved another decisive victory in its ongoing effort to defend truth, innovation, and integrity against baseless attacks from Jason Shurka and The Light System, Inc. ("TLS"). The United States District Court for the Eastern District of New York has formally granted EES permission to move forward with its full motion to dismiss - a strong indication that the court recognizes the legal and factual strength of EES's position. Judges in multiple jurisdictions have now described Shurka's filings as "baseless" and "futile," repeatedly returning the cases to the very courts where EES first initiated them - and where EES continues to win. Truth Over Deception The latest decision follows months of extensive filings exposing what EES alleges was a coordinated campaign of misinformation and brand confusi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom